Bellco, with over 40 years’ experience, operates worldwide offering therapies and systems for the treatment of renal failure, multiple organ failure, sepsis and congestive heart failure with the goal of providing know-how, reliability and innovation to the scientific and medical communities.
Complex clinical conditions, such as those of patients in intensive care, undergoing surgery, with multiple traumas, sepsis, multi-organ failure, cardiopathy, affected by immune pathologies and intoxication, require integrated therapeutic approaches capable of assuring versatility, functionality, rapidity and effectiveness.
The Bellco’s all-embracing sees the integration of the most advanced therapies such as CPFA® for the multi-organ treatment and Abylcap® for safe, efficient and fast removal of CO² in the event of respiratory failure, thanks to advanced equipment: AMPLYA™, the new multiple therapeutic system for the critically patient and CARPEDIEM™, first worldwide therapeutic system designed for neonatal patients.